Novo Nordisk
Jul 11, 2026, 21:43
Sharing New Research in Hemophilia at ISTH 2026 – Novo Nordisk Medical US
Novo Nordisk Medical US shared a post on X:
“Heading to ISTH 2026 in Paris?
We look forward to sharing new research in hemophilia at the congress.
Here is a snapshot of our oral presentations. Feel free to stop by booth 907 to engage with the Novo Nordisk medical team.
Visit the ISTH congress program for more details.”
Proceed to the video attached to the post.
Stay Updated with ISTH 2026 on Hemostasis Today.
-
Aug 14, 2026, 13:43Edward Lee Carter: Optimizing Anticoagulation in Cirrhosis Beyond the Lab Numbers
-
Aug 14, 2026, 13:39Amr Saad: What Tips You Toward Cerebral Venous Thrombosis Over IIH?
-
Aug 14, 2026, 13:28Eduardo Medronha: DIPS as a Rescue Strategy in Budd–Chiari Syndrome
-
Aug 14, 2026, 13:18Immune Checkpoint Inhibitors Have Transformed Cancer Treatment – RPTH Journal
-
Aug 14, 2026, 13:04Mohammed M. Aboudeif: Cerebral Venous Thrombosis – Think Early, Treat Decisively
-
Aug 14, 2026, 12:49Ahmed Hawash: The Hawash Method for Managing Extreme ICU Complexity
-
Aug 14, 2026, 12:42Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma